-
Home > News
News
-
Press Releases
- August 31, 2010
- Naurex’s Novel Antidepressant Glyx-13 Recognized as One of Windhover's Top 10 Neuroscience Projects to Watch
- June 17, 2010
- Naurex Inc. Presents Positive Clinical Data on Novel Mechanism Antidepressant Candidate Glyx-13 at NCDEU 50th Anniversary Meeting
- February 11, 2010
- Naurex Inc. Reports Positive Top-Line Phase I Results for its Novel Mechanism NMDA Receptor Modulator GLYX-13 in Treatment-Resistant Depression
- December 16, 2009
- Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity with No Signs of Classic NMDA-Associated Side Effects
- December 16, 2009
- Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression
Naurex in the News
Naurex Opens the Therapeutic Window for NMDA Modulators, December 29, 2009 – BioWorld Today
Naurex Launches Trial, Looks For Series A, November 17, 2009 – DowJones VentureWire Lifescience